Author Correction: A new coronavirus associated with human respiratory disease in China

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cited by papers we hold 9

• SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal · 2022
  Not checked
• Clinical features predicting COVID-19 mortality risk · 2022
  Not checked
• Therapeutic peptides: current applications and future directions · 2022
  No notice
• Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma · 2021
  Not checked
• Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy · 2021
  No notice
• A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses · 2021
  No notice
• Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? · 2020
  Corrected
• Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography · 2020
  No notice
• Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.